BOSTON--(BUSINESS WIRE)--Sharon Merrill Associates, a leading strategic advisory firm focused on investor relations and strategic corporate communications, announced that it has added food, health, nutrition and industrial specialty ingredients provider Innophos Holdings, Inc. (“Innophos”) to its roster. Through the partnership, Sharon Merrill Associates is providing Innophos with integrated communications services including investor relations, strategic positioning, and corporate communications.
“Sharon Merrill Associates has delivered on their promise to serve as a trusted advisor with a highly strategic approach to communications, meticulous attention to detail, and commitment to results,” said Han Kieftenbeld, Innophos’ senior vice president and chief financial officer. “This is a very important transformational time for our company as we execute against our strategy to be a growing global supplier of vital ingredient solutions for the Food, Health and Nutrition markets. Sharon Merrill Associates’ deep experience and insight, strategic thought process and strong relationships with Wall Street are proving to be key as we work to reposition our story, enhance our investor relations program and build greater awareness for Innophos among the financial community.”
The companies kicked off their partnership this past Fall with the completion of a STREETSCOPE® investor perception audit, which was designed to yield actionable insight from investors. This work informed the design of the integrated strategic communications program for Innophos that includes positioning and messaging, quarterly earnings communications, Wall Street relations outreach and employee communications. Most recently, the companies partnered to execute Innophos’ 2017 Investor Day to introduce Innophos’ new strategic growth roadmap and long-term growth plan ‘Vision 2022: The Path to Revitalized Growth.’
“We are thrilled that Innophos has entrusted Sharon Merrill Associates as its strategic communications partner to help set the course for its transformation,” said Maureen Wolff, chief executive officer of Sharon Merrill. “For more than three decades, clients have trusted us to effectively communicate their story through an array of situations including periods of transformation, mergers & acquisitions and other unplanned events. We take a methodical and informed approach to strategic communications that is rooted in our deep understanding of each client’s business and industry. We look forward to working with Innophos to implement a well-thought out strategic communications program that effectively repositions their story, helps them achieve fair valuation and strengthens their relationships with employees, customers, investors and other critical stakeholders.”
About Sharon Merrill Associates, Inc.
Sharon Merrill Associates is a strategic communications advisory firm that provides investor relations, crisis communications, proxy/activist defense, M&A communications, corporate communications, and presentation and media training. Founded in 1985 and serving public and private client companies in North America and Europe, the firm plans and executes strategic communications that resonate with stakeholders and deliver results. The team has earned wide recognition for communications thought leadership, and is distinguished by its longstanding client relationships.
To learn more about Sharon Merrill Associates, please visit its website, www.InvestorRelations.com.
About Innophos Holdings, Inc.
Innophos is a leading international producer of specialty ingredient solutions that deliver far-reaching, versatile benefits for the food, health, nutrition and industrial markets. We leverage our expertise in the science and technology of blending and formulating phosphate, mineral and botanical based ingredients to help our customers offer products that are tasty, healthy, nutritious and economical. Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations across the United States, in Canada, Mexico and China. For more information, please visit www.innophos.com. 'IPHS-G'
